SENSITIVITY, SPECIFICITY, AND PREDICTIVE VALUE OF FECAL OCCULT BLOOD TESTING (HEMOCCULT-II) FOR COLORECTAL NEOPLASIA IN SYMPTOMATIC PATIENTS - A PROSPECTIVE-STUDY WITH TOTAL COLONOSCOPY
Y. Niv et Ad. Sperber, SENSITIVITY, SPECIFICITY, AND PREDICTIVE VALUE OF FECAL OCCULT BLOOD TESTING (HEMOCCULT-II) FOR COLORECTAL NEOPLASIA IN SYMPTOMATIC PATIENTS - A PROSPECTIVE-STUDY WITH TOTAL COLONOSCOPY, The American journal of gastroenterology, 90(11), 1995, pp. 1974-1977
Objectives: To evaluate the specificity, sensitivity, and positive pre
dictive value of fecal occult blood testing (FOBT) in symptomatic pati
ents, with colonoscopy as the gold standard, and to assess the usefuln
ess of FOBT as an ancillary examination in symptomatic patients for wh
om total colonoscopy is indicated. Methods: We studied 439 consecutive
patients who underwent Hemoccult II testing before total colonoscopy,
Results: The sensitivity, specificity, and positive predictive value
for colorectal neoplasia (cancer and adenomatous polyps) was 76.5%, 56
.7%, and 27.6%, respectively, The sensitivity, specificity, and positi
ve predictive value for colorectal cancer were 69.2%, 73.2%, and 7.3%,
respectively, Conclusions: The sensitivity, specificity, and positive
predictive value of FOBT are difficult to estimate from screening pro
grams, because Hemoccult-negative individuals do not undergo examinati
on of the colon, and many of the Hemoccult-positive cases do not under
go total colonoscopy. With total colonoscopy serving as the gold stand
ard, FOBT does not appear to be of much value as an ancillary examinat
ion in patients with symptoms potentially attributable to the lower ga
strointestinal tract.